Serve You Rx Adds 2 Stelara Biosimilars to Formulary to Help Patients Save Costs
In partnership with Cost Plus Drugs and Waltz Health, Serve You Rx has added Stelara biosimilars Otulfi and Yesintek to its formulary.
HealthJoy, Cost Plus Drugs Partner To Reduce Drug Costs for Employers
HealthJoy and Mark Cuban Cost Plus Drug Company have teamed up. Through the partnership, HealthJoy can now direct the employees of its clients to the drug company when it offers a cheaper option for generic drugs.
presented by
The Top 5 Home Care Franchise Opportunities in the U.S.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Cost Plus Drugs, Talkspace, Health Gorilla Join Wheel’s Virtual Care Ecosystem
With its new partnerships, Wheel is able to connect its customers’ patients with mental health services through Talkspace, home delivery pharmacy services through Cost Plus Drugs and lab and diagnostic services through Health Gorilla.
Why Blue Shield of California Is Shaking Up its Prescription Drug Model
Blue Shield of California is cutting many of its ties with CVS Caremark (though not all) and adding four additional partners for its prescription drug benefits. These partners include Mark Cuban Cost Plus Drug Company and Amazon Pharmacy. The changes are needed to disrupt the current broken system, said Salina Wong, senior director of clinical pharmacy programs at Blue Shield of California.
Scripta Insights Partners with Mark Cuban Cost Plus Drug Company
Through Scripta Insights’ app, members of its customers can input the medications they’re taking, and the company will provide a savings report that will show different options on how they can save on their prescriptions. Starting in 2024, Cost Plus Drugs may show up as an option in the savings report.
How One Company Is Tackling Medication Adherence
Mail order pharmacies like Mark Cuban Cost Plus Drug Company and Amazon's RxPass are gaining popularity. But they're missing in-depth consultations with pharmacists. Aspen RxHealth is trying to fill this gap and sees itself as a potential partner for mail order pharmacies.
presented by
A Path to Healing: Discovering Arizona’s PTSD Treatment Centers
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
Zócalo Health Teams Up with Mark Cuban’s Pharmacy to Increase Medication Access for Latino Patients
Zócalo Health, a virtual primary care provider designed for Latino patients, recently forged a collaboration with Mark Cuban's Cost Plus Drugs. Now all Zócalo patients have access to Cost Plus Drugs’ prescriptions, and the provider's community health workers have been trained to help walk patients through the process of obtaining medications through the pharmacy.
Mark Cuban’s Cost Plus Drugs Turns Focus to Employers
Through the partnership, the organizations are launching EmsanaRx Plus. The product supplements employers' current pharmacy benefit offerings and provides access to Cost Plus Drugs' discounted medications.
Competitor: We Are an Established Option Vis-a-Vis Cuban’s Pharmacy Startup
A customer of Cost Plus Drugs received an email from the company in October stating that “due to skyrocketing demand,” shipping times have been delayed. Marley Drug, a competitor, said its company has not experienced delays and presented itself as an alternative for Americans.
Capital Blue Cross to bring low-cost pharmacy option to members and non-members in 2023
It is Mark Cuban Cost Plus Drug Company's first collaboration with a health plan. The pharmacy company will not be replacing Capital Blue Cross' existing pharmacy benefits manger, but instead will be an additional option for members to choose.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Improving the patient financial experience requires an end to ‘mafia’-style price negotiations
The patient financial experience in the U.S. is poor — patients have a hard time understanding pricing data and they often face exorbitant prices for care and medications. This problem will only get better if the healthcare industry rids itself of price-gouging middlemen and closed-door price negotiations held by businesspeople, according to a recent healthcare innovation panel.
In the current venture climate, tech for pharma is recession-proof
Specialty drugs reportedly reached 50 percent of all drug spending in 2020, a figure that has increased significantly over the last decade.